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Abstract
Objective: To verify the hydrogen-ion potential (pH) of dobutamine hydrochloride solutions under environmental 
conditions similar to those of neonatal intensive care units.
Methods: We analyzed the pH of the drug diluted in 5% dextrose in water or 0.9% NaCl under different conditions 
of temperature (22 and 37 ºC) and light (dark, fluorescent light bulbs, and phototherapy equipment), using colorless 
and amber intravenous sets at time intervals of 0, 1, 24, 48, 72, and 96 hours.
Results: The pH values of the marketed form of the drug and the diluted drug were similar. The pH means were 
3.45±0.19 at 22 °C and 3.55±0.20 at 37 °C. The average of the pH according to light conditions were as follows: in 
the dark = 3.62±0.09, under room light = 3.63±0.07, and exposed to phototherapy = 3.31±0.16. Solutions stored 
in colorless intravenous sets had a lower mean (3.41±0.24) than those kept in amber intravenous sets (3.52±0.15). 
We found lower pH values in the solutions exposed to phototherapy using colorless intravenous sets (3.17±0.03) 
than in those using amber intravenous sets (3.55±0.03).
Conclusion: There was higher variation in the pH of the solutions exposed to phototherapy, and the use of amber 
intravenous sets reduced such effect.
J Pediatr (Rio J). 2009;85(6):553-556: Neonatal nursing, intensive care, drug stability, dobutamine, intravenous 
infusions, medication errors.
Introduction
Drugs and solutions are considered to be stable when 
they keep up to 90% of their chemical activity and physical 
properties unchanged. Temperature has an influence on 
the rate of chemical reactions because it promotes higher 
kinetic energy than the activation energy, and light energy 
may cause molecular decomposition with binding breakdown 
or rearrangement produced by photolysis.1,2
One of the indicators of the chemical behavior is 
the hydrogen-ion potential (pH) value. Drug stability is 
inversely proportional to the difference from the optimal 
pH value.1,2
Concern has been raised in the clinical practice regarding 
the influence of the environmental characteristics of neonatal 
intensive care units (NICUs), such as the action of heat and 
light originated by the use of incubators and phototherapy 
equipment, respectively, on drug stability.
Dobutamine hydrochloride is widely used at NICUs and 
its pH value may range between 2.5 and 5.5.3 However, 
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we could not find in the literature studies on the stability of 
this drug at temperatures higher than 25 ºC or exposed to 
irradiance and light intensity comparable to those produced 
by phototherapy equipment.4-10
Since drug administration under preestablished 
environmental conditions is essential for the maintenance of 
drug stability and, as a consequence, for providing adequate 
treatment, promoting patient’s safety, and supporting 
the clinical practice of the nursing team responsible for 
administrating the solutions,11 the objective of the present 
study was to verify the pH of dobutamine hydrochloride 
solutions throughout time under varied temperatures, light 
conditions, and using different intravenous administration 
systems (IAS) simulating the clinical practice of nursing 
teams at NICUs.
Method
This experimental study was approved by the Research 
Ethics Committee, and data collection was conducted at a 
laboratory environment between May and July 2007.
The sample comprised 180 pH values of dobutamine 
hydrochloride and 5% dextrose in water (DW5) and 0.9% 
NaCl (NS) diluents in its marketed form and solutions 
composed of these elements at a concentration of 7 mg/
mL according to the study conditions and at predefined 
periods of time.
Solutions were stored in IAS using a graduated glass 
tube (burette). For explanatory purposes, the extension 
of the intravenous set used previously to the installation 
of the infusion pump was defined as proximal portion, and 
the extension used after installation of the infusion bomb 
was of distal portion.
We used conventional phototherapy equipment, featuring 
fluorescent light bulbs, with a constant mean distance of 
48 cm between the device and the distal portion of the 
intravenous set. Irradiance was measured using a radiometer 
located at a distance of 48 cm.
A luxmeter was used to measure the light intensity of 
the fluorescent light bulbs falling upon the burette (mean 
of 430 lx) and upon the distal portion of the intravenous set 
(mean of 230 lx). We also measured the illumination at 48 
cm from the phototherapy equipment (mean of 9,000 lx). 
Wrappers used to keep the IAS in the dark allowed light 
incidence of at most 2 lx.
pH measurement was carried out using ExStik pH 
Waterproof Meters, model PH100, Extech® (Waltham, 
Massachusetts, USA). The pH values were determined 
immediately after the electrode is placed in the samples 
of solutions kept in glass beakers. 
After measuring the pH of drugs and diluents in their 
marketed form, the admixtures were placed in burettes 
constituting the study solutions, and pH values were 
measured again. After filling up the intravenous sets, 
samples were collected at 0, 1, 24, 48, 72, and 96 hours 
after infusion. Such times are identified as T0, T1, T2, T3, 
T4, and T5, respectively, representing a pH measurement 
in each situation investigated.
With regards to the temperature, samples were exposed 
to two different situations: when the IAS was kept at 22 ºC 
and when the distal portion entered the incubator adjusted 
at 37 ºC.
Regarding the investigation of light influence, samples 
were exposed to three different conditions: the whole IAS in 
the dark, the system exposed to the lightning of room light 
bulbs, and the solutions contained in the distal portion of 
the intravenous sets exposed to fluorescent light produced 
by the phototherapy equipment.
Dobutamine hydrochloride solutions were stored in two 
types of IAS, colorless (CIAS) and amber (AIAS). Colorless 
devices protected against the light (PIAS) were used for 
controlling the experiment.
The results were manually recorded and stored in 
electronic spreadsheets using descriptive text and figures. 
Analysis of arithmetic mean ± standard deviation was 
used to investigate pH variations in the different situations 
studied.
Results
We analyzed 180 pH values. Of these, 20 (11.1%) were 
measured from samples of dobutamine hydrochloride in its 
marketed form, 20 (11.1%) were DW5 and NS diluents under 
the same condition, 20 (11.1%) were solutions composed of 
these elements, and 120 (66.7%) were samples according 
to the study situation at the predefined time periods.
The pH values of dobutamine hydrochloride aimed 
at dilution in DW5 ranged between 3.10 and 3.31, their 
mean being 3.23±0.06; the pH values of dobutamine 
hydrochloride diluted in NS ranged between 3.07 and 
3.36 with mean value of 3.27±0.08; the pH values of 
DW5 were between 4.43 and 5.10, their mean being 
4.70±0.20; and the pH values of NS ranged from 5.33 
to 6.34 with mean values of 5.86±0.35. The marketed 
form of dobutamine hydrochloride had a mean value of 
3.25±0.07 and, after dilution, the value was 3.49±0.08 
(DW5 3.46±0.08; NS 3.52±0.07).
With regard to the temperature, we found mean pH 
values of 3.45±0.19 for the solutions at 22 ºC and 3.55±0.20 
at 37 ºC.
In terms of illumination, we found mean pH values of 
3.62±0.09 in the dark, 3.63±0.07 under room fluorescent 
lightning, and 3.31±0.16 when exposed to phototherapy 
equipment, with this last situation showing the lowest pH 
values (2.96) and mean (3.15) and the highest variations 
in the solutions (0.31).
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T0 = 0 hour of infusion; T1 = 1 hour of infusion; T2 = 24 hours of infusion; 
T3 = 48 hours of infusion; T4 = 72 hours of infusion; T5 = 96 hours of 
infusion; PIAS = protected intravenous administration system; CIAS = 
colorless intravenous administration system; AIAS = amber intravenous 
administration system.
* Darkness.
†
 Room fluorescent lighting.
‡
 Light emitted by the phototherapy equipment.
Figure 1 - Values of hydrogen-ion potential of dobutamine hy-
drochloride in DW5 according to exposure to light, 
temperature, intravenous administration system and 
time (São Paulo, Brazil, 2007)
T0 = 0 hour of infusion; T1 = 1 hour of infusion; T2 = 24 hours of infusion; 
T3 = 48 hours of infusion; T4 = 72 hours of infusion; T5 = 96 hours of 
infusion; PIAS = protected intravenous administration system; CIAS = 
colorless intravenous administration system; AIAS = amber intravenous 
administration system.
* Darkness.
†
 Room fluorescent lighting.
‡
 Light emitted by the phototherapy equipment.
Figure 2 - Values of hydrogen-ion potential of dobutamine 
hydrochloride in NS according to exposure to light, 
temperature, intravenous administration system and 
time (São Paulo, Brazil, 2007)
The solutions kept in CIAS had lower pH values 
(3.17±0.03) than those placed in AIAS (3.55±0.03).
When exposed to the light energy emitted from a close, 
direct and constant source of fluorescent light bulbs installed 
in the phototherapy equipment, regardless of diluent and 
temperature, the solutions kept in the CIAS had significant 
reduced pH values up to T2, changing from colorless to 
pinkish. On the other hand, the solutions placed in AIAS 
had more constant pH values and did not go through such 
physical alteration (Figures 1 and 2).
Discussion
Drug and diluents, in their marketed form, were found 
to have pH values in agreement with reference values.3
Regardless of the diluent used, pH values of solutions 
remained similar to those of the marketed form of the 
drug and lower than those considered safe for infusion in 
peripheral veins in terms of prevention of local complications 
caused by the intravenous therapy, highlighting the need 
of administration using central catheters.12,13
The small difference between the mean pH values and 
the standard deviation of solutions at 22 or 37 ºC suggests 
that temperature is not responsible for alterations in the 
chemical behavior; however, it was not possible to compare 
such data with the literature due to the lack of studies 
assessing the stability of these solutions at temperatures 
close to 37 ºC.
It is important to mention that most NICUs in Brazil 
do not have controlled thermal conditions and, therefore, 
continuous infusion solutions are exposed to the variations 
of the day-night pattern and to the high temperatures of the 
tropical climate. In addition, there is electronic equipment 
at NICUs which favors environmental warming.
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The small difference in the mean pH values and in its 
variations after comparison of solutions stored in the dark 
with solutions exposed to room fluorescent lightning suggests 
that this type of illumination did not cause any alterations 
in the chemical behavior.
With regard to the change in the color of the solutions 
exposed to close, direct, and constant lightning produced 
by phototherapy equipment, we could not find support in 
the literature to the use of these fluids or to the statements 
that the amount of the therapeutic principle present in such 
fluids is kept up to 90% of its initial concentration. It is also 
not possible to assume that the drug is stable. Experiments 
assessing such solutions by means of high performance 
liquid chromatography (HPLC) are needed.
It is also worth mentioning the need of studies using 
other types of phototherapy, such as Super LED, which emits 
high intensity light by means of a set of LED of superior 
physical-chemical composition.14
According to recommendations of the Centers for 
Disease Control and Prevention (CDC), IAS replacement 
just after 72 hours, provided that they remain closed, is 
classified as category IA.15 Hence, studies guaranteeing the 
stability of dobutamine hydrochloride for a period longer 
than 24 hours could also contribute to the reduction of 
risks of bloodstream infection associated with handling of 
catheters, in addition to providing support to the review of 
residue disposal procedures, collaborating to environmental 
preservation and reduction of hospital costs.
Conclusions
Heat and lighting produced by room fluorescent light 
bulbs seem not to cause changes in the chemical behavior 
of dobutamine hydrochloride solutions; however, it is 
possible to conclude that there is a stronger influence 
of the light produced by the phototherapy equipment 
on the chemical profile of the solution studied and that 
the use of AIAS may contribute to preserve the initial 
characteristics of the drug.
It is important to highlight the relevance of further 
studies on this topic for the detection of alterations 
in the pharmacological concentrations of the solutions 
analyzed with the purpose of verifying if the nursing 
clinical practice related to the care provided to newborns 
at NICUs is adapted to the peculiarities of the drug 
treatment so that routine interventions are based on 
scientific evidence promoting the improvement of nursing 
and, as a consequence, that medical care is increasingly 
beneficial, safe and focused on the integral and individual 
needs of patients and their families.
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